Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New concepts in the treatment of hepatocellular carcinoma
Sabrina Sidali, Eric Trépo, Olivier Sutter, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 765-774
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 81
Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1788-1788
Open Access | Times Cited: 57
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations
Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh, et al.
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101269-101269
Closed Access | Times Cited: 26
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 9
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
Mario Romeo, Marcello Dallio, Carmine Napolitano, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 252-252
Open Access | Times Cited: 1
LACTB suppresses liver cancer progression through regulation of ferroptosis
Kaixuan Zeng, Na Huang, Nanbin Liu, et al.
Redox Biology (2024) Vol. 75, pp. 103270-103270
Open Access | Times Cited: 6
The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma
Yan Lu, Bo Lin, Mengsen Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, et al.
Journal of Molecular Medicine (2025)
Closed Access
ZNF384 and m6A methylation promote the progression of hepatocellular carcinoma by regulating the interaction between LINC00342 and DAPK1
Shujia Kong, Jiaxun Li, Xin Pan, et al.
Cellular Signalling (2025) Vol. 129, pp. 111666-111666
Closed Access
Salivary Extracellular Vesicles in Detection of Cancers Other than Head and Neck: A Systematic Review
Wojciech Owecki, Karolina Wojtowicz, Kacper Nijakowski
Cells (2025) Vol. 14, Iss. 6, pp. 411-411
Open Access
USP39/SMC4 promotes hepatoma cell proliferation and 5-FU resistance
Bo Zhou, Jie Li, Shuai Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring the Etiology and Management of Intermediate Stage Hepatocellular Carcinoma in a Tertiary Care Center in South India
Megha Sharma, Deepak Kannan, S. Muhammed Shahanas, et al.
Gastroenterology Hepatology and Endoscopy Practice (2025) Vol. 5, Iss. 2, pp. 57-60
Closed Access
Non-invasive assessment of response to transcatheter arterial chemoembolization for hepatocellular carcinoma with the deep neural networks-based radiomics nomogram
Yushuang Liu, Haohuan Li, Xinhua Li, et al.
Acta Radiologica (2024) Vol. 65, Iss. 6, pp. 535-545
Closed Access | Times Cited: 4
Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report
Shaobo Zhang, Shugeng Zhang
Transplantation Proceedings (2025)
Open Access
Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
Anna Fichtl, Thomas Seufferlein, Eugen Zizer
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Evaluation of the Safety and Efficacy of Conventional Transarterial Chemoembolization (cTACE) and Drug-Eluting Bead (DEB)-TACE in the Management of Unresectable Hepatocellular Carcinoma: A Systematic Review
Javaria Ayyub, Karan Nareshbhai Dabhi, Namra Vinay Gohil, et al.
Cureus (2023)
Open Access | Times Cited: 9
Circulating microRNAs as biomarkers for stratifying different phases of liver cancer progression and response to therapy
Lucilla D’Abundo, Cristian Bassi, Elisa Callegari, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis
Meng‐Hsuan Kuo, Chih‐Wei Tseng, Ching‐Sheng Hsu, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2426-2426
Open Access | Times Cited: 8
Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma
Rebeca Escutia-Gutiérrez, Ana Sandoval-Rodríguez, Adalberto Zamudio‐Ojeda, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 21, pp. 6867-6867
Open Access | Times Cited: 8
The Role of Ablative Techniques in the Management of Hepatocellular Carcinoma: Indications and Outcomes
Asanda Koza, Ricky H. Bhogal, Nicos Fotiadis, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1062-1062
Open Access | Times Cited: 7
Deletion of Cd44 Inhibits Metastasis Formation of Liver Cancer in Nf2-Mutant Mice
Monserrat Gerardo‐Ramírez, Vanessa Giam, Diana Becker, et al.
Cells (2023) Vol. 12, Iss. 9, pp. 1257-1257
Open Access | Times Cited: 7
WGCNA combined with machine learning to find potential biomarkers of liver cancer
Jiahao Lv, Ajiao Hou, Shi-Hao Zhang, et al.
Medicine (2023) Vol. 102, Iss. 50, pp. e36536-e36536
Open Access | Times Cited: 7
NDC1 promotes hepatocellular carcinoma tumorigenesis by targeting BCAP31 to activate PI3K/AKT signaling
Yaping Liu, Gang Guo, Mudan Ren, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 2
Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling
Larissa M. Bomfim, Sara P. Neves, Amanda M. R. M. Coelho, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top